Tags : Accelerate

Sarepta Therapeutics Collaborates with University of Florida to Accelerate the

Shots: Sarepta to fund four research programs at the UF and will get an exclusive option to develop any new therapeutic compounds resulting from the funded research programs. The projects include exploratory research in novel gene therapy vectors, next-generation capsids, and gene editing technologies along with new therapeutic areas in degenerative genetic diseases The focus […]Read More

Ovid Therapeutics and University of Connecticut Collaborate to Accelerate the

Shots: Ovid will collaborate with UConn’s Stormy J. Chamberlain and secures exclusive access to identified genetic sequences for shRNA-based therapy. Ovid plans to leverage its translational medicine capabilities and drug development expertise in Angelman syndrome to advance OV101 into clinical Ovid is developing OV101 for Angelman syndrome to restore tonic inhibition addressing several core symptoms […]Read More

Merck Collaborates with Yumanity to Accelerate the Development of Two

Shots: Yumanity will receive $500M upfront and milestones along with royalties on net sales of therapies, in exchange Merck to get an exclusive right to two novels Yumanity’s pipeline programs for the treatment of ALS and FTLD The collaboration integrates Yumanity’s drug discovery platform with Merck’s development and commercialization expertise in neuroscience    Yumanity and […]Read More

Janssen Collaborates with Emergent BioSolutions to Accelerate the Manufacturing of

Shots: Janssen partnered with Emergent to develop more than a billion doses of a COVID-19 vaccine candidate, as it anticipates scaling up global manufacturing of its potential treatment. The agreement valued ~135M Emergent will provide manufacturing services with its molecule-to-market CDMO offering, beginning in 2020 and will reserve operations capacity to support manufacturing of J&J’s […]Read More

Blackstone and Alnylam Enter into a Collaboration to Accelerate the

Shots: Blackstone to invest $2B in Alnylam that includes $1B in committed payments in exchange of 50% royalties and commercial milestones for inclisiran, ~$750M in a first lien senior secured term loan led by GSO, ~$150M for Alnylam’s cardiometabolic programs (vutrisiran and ALN-AGT) and ~$100M on purchase of Alnylam’s common stock The transaction marks the […]Read More

Eli Lilly and ISDH Collaborate to Accelerate the Testing for

Shots: Eli Lilly partnered with the Indiana State Department of Health, in support from FDA to hasten testing for SARS-CoV-2 in Indiana  Eli Lilly will utilize its research laboratories for analyzing samples taken at Hoosier healthcare facilities, including nursing homes and emergency rooms. Additionally, Lilly is piloting a drive-thru testing system enable to test patients […]Read More

Johnson & Johnson Collaborates with the Beth Israel Deaconess Medical

Shots: The collaboration leads to the starting of pre-clinical testing of multiple vaccine prospects, intending to identify the vaccine candidate for clinical studies, by the month-end Janssen will utilize its AdVac and PER.C6 technologies (technologies that were used to develop Ebola, Zika, RSV, & HIV vaccine) for rapidly upscale production of an optimal vaccine candidate. J&J […]Read More

Iktos and SRI Collaborate to Accelerate Discovery and Development of

Shots: The collaboration will combine Iktos’ generative modeling AI technology with SRI’s SynFini synthetic chemistry platform to develop optimized compound & to facilitate the identification of drug therapies treating multiple viruses, including influenza and COVID-19 Iktos’AI technology is based on deep generative models that speed up the drug discovery process by automatically designing virtual novel […]Read More

­WHO to Accelerate Global Research and Innovation Against Corona Virus

Shots: WHO convoke global research and innovation forum to be held on Feb 11-12, 2020 in Geneva for mobilization of international action in response to the coronavirus (2019-nCoV) and is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness The forum will involve scientist, public health agencies, ministries of health and research […]Read More

Microsoft Launches $40M AI Program to Accelerate Health Initiatives Globally

Shots: Microsoft launches a $40M, 5yrs. program AI for Health as a part of AI for Good Initiative program to empower researchers and organizations addressing the world’s toughest challenges in health The program will work to aid academia and non-profit research organizations for their medical research efforts addressing the global health crises and healthcare discrepancies. […]Read More